Andreas Breitwieser

Andreas Breitwieser is a researcher at the Institute for Synthetic Bioarchitectures, part of the Department of Biotechnology and Food Sciences at the University of Natural Resources and Life Sciences, Vienna (BOKU). He holds a doctoral degree (Dipl.-Ing. Dr.) and is actively engaged in cutting-edge research in synthetic biology and nanobiotechnology. His work is centered on the application of S-layer proteins in nanoscale systems, including vaccine development and bioelectrosensors.

His research interests include synthetic biology, nanobiotechnology, S-layer protein engineering, and their applications in medical diagnostics and therapeutics. He has contributed to projects involving the development of S-layer-based vaccines for viral diseases like COVID-19 and the construction of nanoscale fluidic systems. His work bridges fundamental protein science with practical biomedical applications.

Although no recent publications are listed in the provided data, Breitwieser has presented his research at international conferences such as the MRS Fall Meeting and CLINAM Summit, indicating active scholarly engagement. His research has been featured in media outlets discussing the development of tiny bioelectrosensors for detecting inflammation and cancer, highlighting the societal impact of his work.

He has participated in externally funded projects from organizations like FFG and private companies, demonstrating collaboration and innovation in applied research. While no students or awards are listed, his involvement in multi-year research initiatives suggests a role in mentoring and team-based scientific inquiry.

Andreas Breitwieser's work is conducted within a dynamic research environment focused on sustainable biotechnological solutions. His contributions support the advancement of functional protein lattices, nanomaterials, and diagnostic tools, positioning him at the intersection of molecular engineering and biomedical innovation.